HDAC6 and hepatocellular carcinoma: Importantly, HDAC6 inhibition could effectively block the interaction between COUP-TFII and β-catenin, which supported the conclusion that an acetylation modification was involved in regulating β-catenin signaling during hypoxia in HCC cells.